Trung Huynh
Stock Analyst at RBC Capital
(4.82)
# 445
Out of 4,575 analysts
305
Total ratings
75.4%
Success rate
22.3%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,500 | $1,196.03 | +25.41% | 25 | Jul 21, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $175 → $287 | $263.40 | +8.96% | 5 | Jul 21, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $142 | $131.07 | +8.34% | 20 | Jul 16, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $60 | $62.09 | -3.37% | 21 | Jul 10, 2026 | |
| PFE Pfizer | Maintained: Hold | $25 | $24.54 | +1.87% | 36 | Jul 10, 2026 | |
| ABBV AbbVie | Rated: Buy | $260 → $280 | $259.36 | +7.96% | 11 | Jul 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $595 → $660 | $656.01 | +0.61% | 10 | Nov 7, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $29 → $25 | $0.6884 | +3,531.61% | 4 | Aug 15, 2025 | |
| INSM Insmed | Maintained: Buy | $133 → $140 | $106.92 | +30.94% | 10 | Aug 13, 2025 | |
| AMGN Amgen | Maintained: Hold | $326 → $317 | $376.04 | -15.70% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.2 → $1 | $2.03 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $38 | $35.28 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $2.69 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $7.41 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.13 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €10.00 → €13.50 | €9.66 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 700.00 → CHF 580.00 | CHF 548.00 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,600 | kr 1,877 | n/a | 5 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 350.00 | CHF 355.10 | n/a | 12 | Jul 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €44.00 → €40.00 | €51.35 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €14.00 → €12.00 | €11.20 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €105.00 | €158.40 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 670.00 | kr 320.60 | n/a | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €57.00 | €46.06 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 9,000p | 12,670p | n/a | 13 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $31 | $7.58 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | 1,300p → 1,400p | 1,920p | n/a | 13 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €165.00 | €139.15 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €96.00 | €76.03 | n/a | 16 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 90.00 | CHF 126.90 | n/a | 10 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €35.00 | €78.45 | n/a | 1 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $71 | $48.77 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €83.00 | €240.88 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.4 | $28.87 | n/a | 2 | Jun 25, 2020 |
Eli Lilly and Company
Jul 21, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,196.03
Upside: +25.41%
Johnson & Johnson
Jul 21, 2026
Maintained: Buy
Price Target: $175 → $287
Current: $263.40
Upside: +8.96%
Merck & Co.
Jul 16, 2026
Maintained: Buy
Price Target: $142
Current: $131.07
Upside: +8.34%
Bristol-Myers Squibb Company
Jul 10, 2026
Maintained: Hold
Price Target: $60
Current: $62.09
Upside: -3.37%
Pfizer
Jul 10, 2026
Maintained: Hold
Price Target: $25
Current: $24.54
Upside: +1.87%
AbbVie
Jul 10, 2026
Rated: Buy
Price Target: $260 → $280
Current: $259.36
Upside: +7.96%
Regeneron Pharmaceuticals
Nov 7, 2025
Maintained: Hold
Price Target: $595 → $660
Current: $656.01
Upside: +0.61%
Jasper Therapeutics
Aug 15, 2025
Maintained: Buy
Price Target: $29 → $25
Current: $0.6884
Upside: +3,531.61%
Insmed
Aug 13, 2025
Maintained: Buy
Price Target: $133 → $140
Current: $106.92
Upside: +30.94%
Amgen
Aug 6, 2025
Maintained: Hold
Price Target: $326 → $317
Current: $376.04
Upside: -15.70%
May 21, 2025
Maintained: Buy
Price Target: $1.2 → $1
Current: $2.03
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $44 → $38
Current: $35.28
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $10 → $7
Current: $2.69
Upside: n/a
Mar 29, 2025
Maintained: Buy
Price Target: $13 → $12
Current: $7.41
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4
Current: $2.13
Upside: n/a
Aug 24, 2023
Maintained: Hold
Price Target: €10.00 → €13.50
Current: €9.66
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 548.00
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,600
Current: kr 1,877
Upside: n/a
Jul 24, 2022
Maintained: Hold
Price Target: CHF 350.00
Current: CHF 355.10
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: €44.00 → €40.00
Current: €51.35
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: €14.00 → €12.00
Current: €11.20
Upside: n/a
Apr 13, 2022
Maintained: Hold
Price Target: €105.00
Current: €158.40
Upside: n/a
Apr 1, 2022
Maintained: Hold
Price Target: kr 670.00
Current: kr 320.60
Upside: n/a
Dec 13, 2021
Maintained: Hold
Price Target: €57.00
Current: €46.06
Upside: n/a
Nov 15, 2021
Maintained: Buy
Price Target: 9,000p
Current: 12,670p
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $28 → $31
Current: $7.58
Upside: n/a
Jun 22, 2021
Maintained: Sell
Price Target: 1,300p → 1,400p
Current: 1,920p
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: €165.00
Current: €139.15
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: €96.00
Current: €76.03
Upside: n/a
Apr 28, 2021
Maintained: Hold
Price Target: CHF 90.00
Current: CHF 126.90
Upside: n/a
Jan 20, 2021
Maintained: Sell
Price Target: €35.00
Current: €78.45
Upside: n/a
Oct 12, 2020
Maintained: Buy
Price Target: $55 → $71
Current: $48.77
Upside: n/a
Jul 28, 2020
Maintained: Hold
Price Target: €83.00
Current: €240.88
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.4
Current: $28.87
Upside: n/a